Sex;Age group;Perception of risk of infection of HIV/AIDS by injectable drugs;Total
Both sexes;Total;Total;100.00
Both sexes;Total;High risk;59.10
Both sexes;Total;Intermediate risk;9.96
Both sexes;Total;Low or no risk;0.47
Both sexes;Total;Depends on whether they share syringes or not;30.47
Both sexes;From 18 to 29 years of age;Total;100.00
Both sexes;From 18 to 29 years of age;High risk;59.19
Both sexes;From 18 to 29 years of age;Intermediate risk;11.07
Both sexes;From 18 to 29 years of age;Low or no risk;0.50
Both sexes;From 18 to 29 years of age;Depends on whether they share syringes or not;29.24
Both sexes;From 30 to 39 years of age;Total;100.00
Both sexes;From 30 to 39 years of age;High risk;57.06
Both sexes;From 30 to 39 years of age;Intermediate risk;9.68
Both sexes;From 30 to 39 years of age;Low or no risk;0.46
Both sexes;From 30 to 39 years of age;Depends on whether they share syringes or not;32.81
Both sexes;From 40 to 49 years of age;Total;100.00
Both sexes;From 40 to 49 years of age;High risk;61.37
Both sexes;From 40 to 49 years of age;Intermediate risk;8.87
Both sexes;From 40 to 49 years of age;Low or no risk;0.45
Both sexes;From 40 to 49 years of age;Depends on whether they share syringes or not;29.31
Males;Total;Total;100.00
Males;Total;High risk;59.30
Males;Total;Intermediate risk;11.71
Males;Total;Low or no risk;0.68
Males;Total;Depends on whether they share syringes or not;28.30
Males;From 18 to 29 years of age;Total;100.00
Males;From 18 to 29 years of age;High risk;59.03
Males;From 18 to 29 years of age;Intermediate risk;12.55
Males;From 18 to 29 years of age;Low or no risk;0.79
Males;From 18 to 29 years of age;Depends on whether they share syringes or not;27.63
Males;From 30 to 39 years of age;Total;100.00
Males;From 30 to 39 years of age;High risk;57.81
Males;From 30 to 39 years of age;Intermediate risk;11.21
Males;From 30 to 39 years of age;Low or no risk;0.60
Males;From 30 to 39 years of age;Depends on whether they share syringes or not;30.38
Males;From 40 to 49 years of age;Total;100.00
Males;From 40 to 49 years of age;High risk;61.45
Males;From 40 to 49 years of age;Intermediate risk;11.21
Males;From 40 to 49 years of age;Low or no risk;0.63
Males;From 40 to 49 years of age;Depends on whether they share syringes or not;26.71
Females;Total;Total;100.00
Females;Total;High risk;58.89
Females;Total;Intermediate risk;8.16
Females;Total;Low or no risk;0.26
Females;Total;Depends on whether they share syringes or not;32.69
Females;From 18 to 29 years of age;Total;100.00
Females;From 18 to 29 years of age;High risk;59.35
Females;From 18 to 29 years of age;Intermediate risk;9.53
Females;From 18 to 29 years of age;Low or no risk;0.20
Females;From 18 to 29 years of age;Depends on whether they share syringes or not;30.92
Females;From 30 to 39 years of age;Total;100.00
Females;From 30 to 39 years of age;High risk;56.28
Females;From 30 to 39 years of age;Intermediate risk;8.09
Females;From 30 to 39 years of age;Low or no risk;0.32
Females;From 30 to 39 years of age;Depends on whether they share syringes or not;35.32
Females;From 40 to 49 years of age;Total;100.00
Females;From 40 to 49 years of age;High risk;61.30
Females;From 40 to 49 years of age;Intermediate risk;6.54
Females;From 40 to 49 years of age;Low or no risk;0.27
Females;From 40 to 49 years of age;Depends on whether they share syringes or not;31.89